# Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease

> **NCT05355064** · PHASE4 · UNKNOWN · sponsor: **Neuromed IRCCS** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Trehalose

## Key facts

- **NCT ID:** NCT05355064
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05
- **Primary completion:** 2022-08-31
- **Final completion:** 2023-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05355064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05355064, "Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05355064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*